Skip to content

Neuropace, Inc. NPCE Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$15.63M-28.3%$21.81M+5.0%$20.77M-9.6%$22.98M-15.3%$27.14M+100%
$39.2M-0.4%$39.37M0.0%$39.37M+0.2%$39.28M+0.1%$39.24M-0.2%
$852K+598%$122K0.0%$122K0.0%$122K0.0%$122K0.0%
$57.96M-1.1%$58.61M+3.2%$56.78M+6.3%$53.4M+4.5%$51.09M+8.0%
$68.07M+4.8%$64.96M+5.7%$61.44M+10.9%$55.39M+9.9%$50.41M+4.5%
$6.11M-1.5%$6.21M-3.5%$6.44M+1.9%$6.31M+49.7%$4.22M+9.0%
$4.38M+57.6%$2.78M+18.1%$2.35M+56.8%$1.5M-29.5%$2.13M-1.2%
$6.2M-21.6%$7.91M-15.4%$9.35M+9.6%$8.53M+18.0%$7.23M-1.7%
$6.9M-9.0%$7.58M-10.8%$8.5M+1.5%$8.37M-4.4%$8.75M-0.7%
$86.98M-7.5%$94.07M-1.3%$95.33M+1.7%$93.74M-3.8%$97.48M+19.8%
$1.28M+14.0%$1.13M+1.5%$1.11M-4.2%$1.16M-0.3%$1.16M+10.3%
$8.27M+0.7%$8.21M+1.0%$8.13M+0.7%$8.07M+0.7%$8.02M+0.5%
8.5%0.0%8.5%0.0%8.5%0.0%8.5%0.0%8.5%0.0%
$106K-6.2%$113K-5.8%$120K+37.9%$87K+480%$15K0.0%
$39.2M-0.4%$39.37M0.0%$39.37M+0.2%$39.28M+0.1%$39.24M-0.2%
$98.9M-6.3%$105.57M-1.6%$107.26M+1.1%$106.11M-3.7%$110.21M+16.4%
$16.04M+3.0%$15.57M-4.5%$16.31M+17.5%$13.88M+21.2%$11.45M+7.3%
$7M-33.3%$10.49M+1.2%$10.37M+46.5%$7.08M+19.9%$5.91M-28.9%
$126K-10.6%$141K-78.3%$649K-6.8%$696K+2.4%$680K+22.5%
$2.19M+3.3%$2.12M+3.2%$2.05M+3.3%$1.99M+3.3%$1.92M+3.4%
$16.17M-9.2%$17.81M-9.1%$19.61M+14.4%$17.14M+16.6%$14.71M-3.0%
$59.02M+0.2%$58.88M+0.2%$58.75M+0.2%$58.62M-2.0%$59.79M+0.4%
$9.26M-5.9%$9.84M-5.3%$10.38M-4.9%$10.92M-4.6%$11.44M-4.3%
$11.44M-4.3%$11.95M-3.9%$12.43M-3.6%$12.9M-3.4%$13.36M-3.3%
$0$0$0$0$0
$0$0$0$0$0
200M0.0%200M0.0%200M0.0%200M0.0%200M0.0%
$573.52M+0.4%$571.41M+0.6%$568.17M+0.5%$565.6M+0.7%$561.78M+4.2%
-$559.1M-1.2%-$552.42M-0.5%-$549.69M-0.6%-$546.19M-1.6%-$537.54M-1.2%
$14.45M-24.1%$19.03M+2.8%$18.52M-4.7%$19.44M-19.9%$24.27M+203%
$98.9M-6.3%$105.57M-1.6%$107.26M+1.1%$106.11M-3.7%$110.21M+16.4%
$54M-11.6%$61.1M+1.8%$60M-3.4%$62.1M-6.3%$66.3M+25.6%
$106K-93.8%$1.7M+1,315%$120K+37.9%$87K+480%$15K-98.8%
$9.68M-4.5%$10.13M-4.2%$10.58M-3.9%$11.01M-3.7%$11.43M-3.5%
$9.68M-4.5%$10.13M-4.2%$10.58M-3.9%$11.01M-3.7%$11.43M-3.5%
$106K-6.2%$113K-5.8%$120K+37.9%$87K+480%$15K0.0%
$9.55M+2.3%$9.33M+1.1%$9.23M+0.1%$9.23M+0.6%$9.18M+1.7%
$39.2M-0.4%$39.37M0.0%$39.37M+0.2%$39.28M+0.1%$39.24M-0.2%
$9.68M-4.5%$10.13M-4.2%$10.58M-3.9%$11.01M-3.7%$11.43M-3.5%
$106K-6.2%$113K-5.8%$120K+37.9%$87K+480%$15K0.0%
$0$0$0$0$0
$7M-33.3%$10.49M+1.2%$10.37M+46.5%$7.08M+19.9%$5.91M-28.9%
$9.34M-29.9%$13.34M+8.3%$12.32M+26.5%$9.74M+20.9%$8.06M-17.7%
$9.34M-29.9%$13.34M+8.3%$12.32M+26.5%$9.74M+20.9%$8.06M-17.7%
$7M-33.3%$10.49M+1.2%$10.37M+46.5%$7.08M+19.9%$5.91M-28.9%
$3.22M+3.0%$3.12M0.0%$3.12M0.0%$3.12M0.0%$3.12M+3.0%
$1.7M-45.4%$3.12M-5.7%$3.31M0.0%$3.31M0.0%$3.31M+3.0%
$3.22M+3.0%$3.12M0.0%$3.12M0.0%$3.12M0.0%$3.12M+3.0%
$3.31M+3.0%$3.22M0.0%$3.22M0.0%$3.22M0.0%$3.22M+3.0%
$3.31M0.0%$3.31M0.0%$3.31M+3.0%
$3.12M+3.0%$3.03M0.0%$3.03M0.0%$3.03M0.0%$3.03M+3.0%
$13.63M-5.3%$14.38M-4.9%$15.12M-4.6%$15.86M-4.4%$16.59M-4.2%
$2.19M-10.1%$2.43M-9.5%$2.69M-9.0%$2.95M-8.5%$3.23M-8.1%
$203K-45.7%$374K-24.0%$492K-12.5%$562K-27.9%$779K+1,458%
$3.31M+3.0%$3.22M0.0%$3.22M0.0%$3.22M0.0%$3.22M+3.0%
$3.31M0.0%$3.31M+3.0%$3.22M0.0%$3.22M0.0%$3.22M-2.9%
$1.7M-48.6%$3.31M0.0%$3.31M0.0%$3.31M0.0%$3.31M+3.0%
$70.46M-0.5%$70.84M-0.5%$71.18M-0.5%$71.52M-2.2%$73.15M-0.3%
$0.000.0%$0.000.0%$0.000.0%$0.000.0%$0.000.0%
33.9M+1.0%33.6M+0.9%33.3M+0.7%33M+0.9%32.8M+8.6%
10M0.0%10M0.0%10M0.0%10M0.0%10M0.0%
00000
00000
$34K0.0%$34K+3.0%$33K0.0%$33K0.0%$33K+10.0%
$0$0$0$0$0
$16.96M-24.6%$22.51M+1,190%$1.75M+3.8%$1.68M+4.3%$1.61M+2.8%
2.6M-1.6%2.6M-1.6%2.6M-0.9%2.7M+4.4%2.6M+7.8%
$0.000.0%$0.000.0%$0.000.0%$0.000.0%$0.000.0%
2.6M-1.6%2.6M-1.6%2.6M-0.9%2.7M+4.4%2.6M+7.8%
$18.4M+16.5%$15.8M-13.2%$18.2M-11.2%$20.5M-3.3%$21.2M+41.3%
8.5M+18.9%7.1M-4.0%7.4M-3.1%7.7M-3.7%8M+21.8%
$0-100%$200K0.0%$200K+100%$100K
$7.20+1.6%$7.09+1.3%$7.00+1.6%$6.89+5.4%$6.54+8.8%
$7.20+1.6%$7.09+1.3%$7.00+1.6%$6.89+5.4%$6.54+8.8%
$9.55M+2.3%$9.33M+1.1%$9.23M+0.1%$9.23M+0.6%$9.18M+1.7%
$9.34M-29.9%$13.34M+8.3%$12.32M+26.5%$9.74M+20.9%$8.06M-17.7%
$731K-16.4%$874K+101%$435K-34.6%$665K+74.5%$381K-33.7%
$203K-45.7%$374K-24.0%$492K-12.5%$562K-27.9%$779K+1,458%
$0-100%$200K0.0%$200K+100%$100K
$8.47M+18.9%$7.13M-4.0%$7.42M-3.1%$7.66M-3.7%$7.95M+21.8%
$00.0%$00.0%$00.0%$00.0%$00.0%
$200M0.0%$200M0.0%$200M0.0%$200M0.0%$200M0.0%
$33.91M+1.0%$33.57M+0.9%$33.28M+0.7%$33.04M+0.9%$32.75M+8.6%
$33.91M+1.0%$33.57M+0.9%$33.28M+0.7%$33.04M+0.9%$32.75M+8.6%
$18.4M+16.5%$15.8M-13.2%$18.2M-11.2%$20.5M-3.3%$21.2M+41.3%
$6.11M-1.5%$6.21M-3.5%$6.44M+1.9%$6.31M+49.7%$4.22M+9.0%
$39.2M-0.4%$39.37M0.0%$39.37M+0.2%$39.28M+0.1%$39.24M-0.2%
$13.63M-5.3%$14.38M-4.9%$15.12M-4.6%$15.86M-4.4%$16.59M-4.2%
$2.19M-10.1%$2.43M-9.5%$2.69M-9.0%$2.95M-8.5%$3.23M-8.1%
$0$0$0$0$0
$0.090.0%$0.090.0%$0.090.0%$0.090.0%$0.090.0%
$819K-4.7%$859K-15.6%$1.02M+2.9%$989K-0.1%$990K+86.1%
$00.0%$00.0%$00.0%$00.0%$00.0%
$10M0.0%$10M0.0%$10M0.0%$10M0.0%$10M0.0%
$0$0$0$0$0
$0$0$0$0$0
$1.9M+26.7%$1.5M+87.5%$800K-50.0%$1.6M-11.1%$1.8M+5.9%
$7.2+1.6%$7.09+1.3%$7+1.6%$6.89+5.4%$6.54+8.8%
$1.89M+5.7%$1.79M+2.7%$1.75M+3.8%$1.68M+4.3%$1.61M+2.8%
$2.56M-1.6%$2.6M-1.6%$2.64M-0.9%$2.67M+4.4%$2.55M+7.8%
$2.56M-1.6%$2.6M-1.6%$2.64M-0.9%$2.67M+4.4%$2.55M+7.8%
$7.2+1.6%$7.09+1.3%$7+1.6%$6.89+5.4%$6.54+8.8%
$6.13+7.4%$5.71+4.4%$5.47+5.6%$5.18+2.4%$5.06+12.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Neuropace, Inc.'s total assets?
Neuropace, Inc. (NPCE) holds $98.9M in total assets, down 10.3% year over year.
How much debt does Neuropace, Inc. have?
Neuropace, Inc. carries $70.5M in total debt against $14.5M of shareholders' equity, a debt-to-equity ratio of 4.87.
How much cash does Neuropace, Inc. have?
Neuropace, Inc. holds $15.6M in cash and equivalents.
Can Neuropace, Inc. cover its short-term obligations?
Its current ratio is 5.38 — current assets exceed current liabilities.
Where does Neuropace, Inc.'s balance sheet data come from?
Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.